DeSelm honored by NIH for innovative cancer research
Radiation oncologist Carl J. DeSelm, MD, PhD, has been honored by the National Institutes of Health (NIH) for his visionary research to harness the immune system to fight cancer.
DeSelm, an assistant professor of radiation oncology, is one of 89 researchers to be recognized by the NIH for innovative research as part of its High-Risk, High-Reward Research Program. The program supports high-risk ideas with high-impact potential and encourages exceptional creativity and thinking outside the box.
DeSelm will receive the NIH Director’s Early Independence Award. This year, the award provides $1.25 million over five years to each of 11 scientists from all fields around the nation doing unusually innovative work with the potential for broad impact in biomedical research fields. Established in 2011, the award supports exceptional junior faculty as they begin to build independent research labs.